Patent · US Active

Piperidinyl compounds that selectively bind integrins

US7879881B2 · kind B2 · utility

0Cited by

9References

41Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Bart De Corte · Southampton, US
William A. Kinney · Newtown, US
Bruce E. Maryanoff · Robinson Township, US
Shyamali Ghosh · Norristown, US
Li Liu · Beijing, CN

Key dates

Filing date	Aug 30, 2007
Grant date	Feb 1, 2011
Priority date	—
Expiry date	Apr 1, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to piperidinyl compounds that selectively bind integrin receptors and methods for treating an integrin mediated disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.